Foamix Pharmaceuticals (Foamix Pharmaceuticals) EV-to-Revenue : 413.43 (As of May. 06, 2024)

Foamix Pharmaceuticals EV-to-Revenue Chart

Foamix Pharmaceuticals Quarterly Data
	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19
EV-to-Revenue	Get a 7-Day Free Trial															26.85	41.29	30.56	107.66	377.94

Competitive Comparison of Foamix Pharmaceuticals's EV-to-Revenue

For the Biotechnology subindustry, Foamix Pharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Foamix Pharmaceuticals's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Foamix Pharmaceuticals's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Foamix Pharmaceuticals's EV-to-Revenue falls into.

Foamix Pharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Foamix Pharmaceuticals's EV-to-Revenue for today is calculated as:

Foamix Pharmaceuticals's current Enterprise Value is $183.15 Mil.
Foamix Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Dec. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.44 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Foamix Pharmaceuticals  (NAS:FOMX) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Foamix Pharmaceuticals's PS Ratiofor today is calculated as:

Foamix Pharmaceuticals's share price for today is $2.99.
Foamix Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Foamix Pharmaceuticals EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Foamix Pharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Foamix Pharmaceuticals (Foamix Pharmaceuticals) Business Description